Obesity is particularly significant, as excess adipose tissue increases lymphatic load and may directly impair lymphatic vessel function through inflammatory mechanisms
On average, after 72 weeks of treatment on the highest 7.2mg maintenance dose, Wegovy can help you lose 21% of your starting body weight
insert the needle at 4590 into subcutaneous tissue [12] [13]
In recent years, Novo Nordisks injectable Wegovy and Lillys Zepbound have revolutionized obesity treatment globally and in the U.S., where 100 million people have the chronic disease
[DOI] [PubMed] [Google Scholar] 60.Hashimoto T., Ozaki Y., Taminato M., et al
Sources Ready to explore peptide therapy for weight loss in Stamford, CT